Amgen Is Still ‘A Biotech At Heart’
Exclusive Interview With Kave Niksefat
Executive Summary
Head of Amgen’s inflammation business, Kave Niksefat, gives insight into how the 40-year-old biotech maintains its culture of innovation and avoids falling into the “trap” of bureaucracy.